WCN26-5363 INFLUENCE OF EXPANDING THERAPEUTIC OPTIONS ON REMISSION INDUCTION STRATEGIES AND OUTCOMES IN ANCA-ASSOCIATED VASCULITIS: A SINGLE-CENTER RETROSPECTIVE STUDY

Read full text Summarise with VIRAT
Authors: Yuki Nakayama, Makoto Harada, Koji Hashimoto, Yuji Kamijo
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The therapeutic landscape of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) has evolved considerably following the approval of rituximab (RTX) and, more recently, the introduction of avacopan. These advances have diversified remission induction strategies. However, their impact on real-world clinical practice and outcomes remains uncertain. This study aimed to evaluate temporal changes in induction therapy patterns and to assess short-term renal and survival outcomes, as well as safety outcomes, before and after the introduction of RTX at our institution.

Fields of Study & Subjects

Vasculitis and related conditions Renal Diseases and Glomerulopathies Renal Transplantation Outcomes and Treatments

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
106240–106240
Publication date
25 March 2026
Language
EN